Chondrocyte apoptosis: Implications for osteochondral allograft transplantation

28Citations
Citations of this article
57Readers
Mendeley users who have this article in their library.

Abstract

Osteochondral allograft transplantation is a useful technique to manage larger articular cartilage injuries. One factor that may compromise the effectiveness of this procedure is chondrocyte cell death that occurs during the storage, preparation, and implantation of the osteochondral grafts. Loss of viable chondrocytes may negatively affect osteochondral edge integration and long-term function. A better understanding of the mechanisms responsible for chondrocyte loss could lead to interventions designed to decrease cell death and improve results. Recent studies indicate that apoptosis, or programmed cell death, is responsible for much of the chondrocyte death associated with osteochondral allograft transplantation. Theoretically, some of these cells can be rescued by blocking important apoptotic mediators. We review the role of apoptosis in cartilage degeneration, focusing on apoptosis associated with osteochondral transplantation. We also review the pathways thought to be responsible for regulating chondrocyte apoptosis, as well as experiments testing inhibitors of the apoptotic pathway. These data suggest that key contributors to the apoptotic process can be manipulated to enhance chondrocyte survival. This knowledge may lead to better surgical outcomes for osteochondral transplantation. © 2008 The Association of Bone and Joint Surgeons.

Cite

CITATION STYLE

APA

Kim, H. T., Teng, M. S., & Dang, A. C. (2008). Chondrocyte apoptosis: Implications for osteochondral allograft transplantation. In Clinical Orthopaedics and Related Research (Vol. 466, pp. 1819–1825). Springer New York. https://doi.org/10.1007/s11999-008-0304-6

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free